| Title: | Polygenic risk scores reveal shared polygenic risk across across five common cardiovascular diseases. |
| Journal: | Atherosclerosis |
| Published: | 1 Apr 2026 |
| DOI: | https://doi.org/10.1016/j.atherosclerosis.2026.120763 |
| Title: | Polygenic risk scores reveal shared polygenic risk across across five common cardiovascular diseases. |
| Journal: | Atherosclerosis |
| Published: | 1 Apr 2026 |
| DOI: | https://doi.org/10.1016/j.atherosclerosis.2026.120763 |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Background and aim The five cardiovascular diseases (CVDs): Coronary artery disease (CAD), stroke, heart failure (HF), peripheral arterial disease (PAD), and atrial fibrillation(Afib) often co-occur. Most polygenic risk scores (PRSs) are developed for individual CVDs, limiting their clinical utility across multiple CVDs. We investigated associations between five PRSs and (1) their CVDs, (2) cross-disease associations for pleiotropy, and (3) across multimorbidity clusters. Methods We calculated restricted PRSs using genome-wide significant variants from published genome-wide association studies and validated them in 484,154 UK Biobank participants. For the time-to-onset and sequence analysis, we included 34,394 individuals with a CAD diagnosis. We used logistic regression, Cox regression, and accelerated failure time analysis; p ≤ 0.05 was considered significant. Results All PRSs were significantly associated with their respective CVDs (ORs 1.08-1.60 per 1-SD). The odds of CAD increased by 55% per 1-SD increase in PRSCAD (OR 1.55, 95% CI: 1.53-1.57). In cross-disease associations, all 25 PRS-CVD pairs were significant. For some CVDs, PRS from other CVDs showed a stronger association than their own. For instance, HF was more strongly associated with PRSAfib than PRSHF (OR 1.21 vs 1.17). In CAD patients, those in the top 10% of PRSCAD had a 2.66-fold higher PAD risk (HR 2.66, 95% CI: 1.06-6.71) and developed PAD 5.6 years earlier than those in the bottom 10% (time ratio 0.40, 95% CI: 0.17-0.93). Conclusion PRSs reveal shared polygenic risk across CVDs and provide insight into CVD multimorbidity trajectories, such as timing and sequence of events.</p>
| Application ID | Title |
|---|---|
| 67864 | Polygenic risk score transportability across populations and complex traits: characterizing clinical applications of risk profiles within the context of the Genotyping Of ALL (GOALL) project |
Enabling scientific discoveries that improve human health